A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
出版年份 2016 全文链接
标题
A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
作者
关键词
<em class=EmphasisTypeItalic >Clostridium difficile</em>, Cost-effectiveness, Budget impact, Fidaxomicin, Vancomycin
出版物
INFECTION
Volume 44, Issue 5, Pages 599-606
出版商
Springer Nature
发表日期
2016-04-09
DOI
10.1007/s15010-016-0894-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program
- (2015) Teena Chopra et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Recurrent Clostridium difficile infection is associated with increased mortality
- (2015) M.A. Olsen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
- (2015) C. Rubio-Terrés et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital
- (2015) S. M. Heimann et al. INFECTION
- The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
- (2015) Jennie H. Kwon et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Ökonomische Auswirkungen einer Clostridium-difficile-Enterokolitis in deutschen Krankenhäusern auf der Basis von DRG-Kostendaten
- (2015) R. Grube et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison
- (2014) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
- (2014) D. Nathwani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Future Health Economic Potential of Next Generation Artificial Vision Devices for Treating Blindness in Germany: an Early Cost-Utility Assessment
- (2014) B. Schwander VALUE IN HEALTH
- Renal Impairment and Clinical Outcomes of Clostridium difficile Infection in Two Randomized Trials
- (2013) Kathleen M. Mullane et al. AMERICAN JOURNAL OF NEPHROLOGY
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Resolution of Clostridium difficile–Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
- (2013) Oliver A. Cornely et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
- (2013) Paul M. Stranges et al. VALUE IN HEALTH
- Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance
- (2013) Kathleen Mullane Therapeutic Advances in Chronic Disease
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
- (2012) D. W. Eyre et al. CLINICAL INFECTIOUS DISEASES
- Consequences of Clostridium difficile infection: understanding the healthcare burden
- (2012) E. Bouza CLINICAL MICROBIOLOGY AND INFECTION
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
- (2012) P.N. Wiegand et al. JOURNAL OF HOSPITAL INFECTION
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Clostridium difficile Infection: New Insights Into Management
- (2012) Sahil Khanna et al. MAYO CLINIC PROCEEDINGS
- Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
- (2011) Kathleen M. Mullane et al. CLINICAL INFECTIOUS DISEASES
- Treatment of refractory and recurrent Clostridium difficile infection
- (2011) Christina M. Surawicz et al. Nature Reviews Gastroenterology & Hepatology
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Economic healthcare costs of Clostridium difficile infection: a systematic review
- (2010) S.S. Ghantoji et al. JOURNAL OF HOSPITAL INFECTION
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study
- (2009) Denise Gravel et al. CLINICAL INFECTIOUS DISEASES
- Single- Versus Multiple-Dose Antibiotic Prophylaxis in the Surgical Treatment of Closed Fractures: A Meta-Analysis
- (2009) Gerard P Slobogean et al. JOURNAL OF ORTHOPAEDIC TRAUMA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started